Implications on Treatment
In years to come, this research will greatly affect how SLE, and potentially other autoimmune conditions, are treated. One might probably foresee a more focused and specific method of treatment of the disease itself as opposed to a broad spectrum of medicines that addresses the many issues and symptoms.
So far, most treatments address symptoms, inflammation, and prevent (or slow down) damage to the organs or the body’s tissue. In other words, these medications don’t really interact with apoptotic cells in the same manner as DCs. For example, immunosuppressive medications function primarily for the purpose of quelling the body’s immunity to ward off its action against healthy tissue.
The most common and least complex treatments include the following:
- Corticosteroid (topical or injected) for skin irritations and arthritis
- NSAIDS for symptoms related to the joints and muscles or pleurisy
- Hydroxychloroquine and Belimumab